Lack of association between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and pain improvement in patients with oral cancer

BACKGROUND: There is a growing body of literature implicating angiotensin II in the modulation of tumour-associated inflammation and pain. However, the impact of angiotensin-converting enzyme inhibitors (ACEis) and angiotensin II receptor blockers (ARBs) on pain and inflammation has not yet been stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Kim N, Shepherd, Andrew J, Ma, Irvin V, Roldan, Carlos J, Amit, Moran, Feng, Lei M S, Desai, Shubh, Cata, Juan P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652423/
https://www.ncbi.nlm.nih.gov/pubmed/33209112
http://dx.doi.org/10.3332/ecancer.2020.1121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652423/
https://www.ncbi.nlm.nih.gov/pubmed/33209112
http://dx.doi.org/10.3332/ecancer.2020.1121

Ejemplares similares